United States | Apotex Worldwide

About Us

For Media Inquiries, Please Contact:

Jordan Berman
Vice President,
Global Corporate Communications

Apotex Inc.
1 (416) 749-9026 Ext. 7487
Email

Press Center

Dec 7, 2021

Apotex Corp. Announces Approval and Launch of Atropine Sulfate Ophthalmic Solution USP, 1% in the United States